Yahoo Web Search

  1. Ads
    related to Leukemia
  1. Today, the National Comprehensive Cancer Network® (NCCN ®) published new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for Hematopoietic Cell Transplantation (HCT), also ...

  2. Vanguard Health Care Fund Sells Out of Allergan

    GuruFocus.com via Yahoo FinanceNov 05 23:16 PM

    During the quarter, the mutual fund's most significant sale was Allergan PLC (NYSE:AGN). Due to its narrow focus on stocks related to health care, the fund's website advises keeping a long-term ...

  3. Jazz Pharma (JAZZ) Q3 Earnings Beat, Xyrem Drives Sales

    Zacks via Yahoo FinanceNov 06 15:36 PM

    Jazz Pharmaceuticals plc JAZZ delivered adjusted earnings of $4.10 per share for the third quarter of 2019, which surpassed the Zacks Consensus Estimate of $3.59. Total revenues in the reported ...

  4. On August 3, 2019, just days before his 21st birthday, Nikolas was diagnosed with Acute Myeloid Leukemia (AML) and admitted to the City of Hope in Duarte, Calif. to begin chemotherapy ...

  5. AbbVie Inc on Friday forecast 2019 revenue above Wall Street estimates and expressed confidence in future sales of blockbuster wrinkle treatment Botox, which it will acquire with its $63 billion ...

  6. Edited Transcript of SYN earnings conference call or presentation 4-Nov-19 9:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceNov 08 23:08 PM

    Today, I'll be providing a brief update on our portfolio of GI and microbiome-focused clinical programs, which leverage the gut microbiome to improve patient incomes, and then I'll share our ...

  7. Edited Transcript of APS.TO earnings conference call or presentation 5-Nov-19 10:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceNov 06 11:08 AM

    As we announced in July, we initiated dosing of 806 in heavily pretreated patient with chronic lymphocytic leukemia or CLL, starting at the oral dose of 150 milligrams BID or twice daily ...

  8. AVEO Pharmaceuticals, Inc. AVEO reported earnings of 10 cents per share in the third quarter of 2019, surpassing the Zacks Consensus Estimate of 1 cent. It also rebounded from the year-ago loss of 18 cents.

  9. Edited Transcript of FATE earnings conference call or presentation 5-Nov-19 10:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceNov 09 18:02 PM

    The FT516 clinical trial is a multidose Phase I clinical trial in which FT516 is being investigated as a monotherapy for the treatment of relapsed refractory acute myeloid leukemia and ...

  10. NEW YORK, Nov. 10, 2019 /PRNewswire/ -- The Lupus Research Alliance (LRA) is pleased to acknowledge positive results presented at the American Society of Nephrology (ASN) and the 2019 ACR/ARP ...

  1. Ads
    related to Leukemia